small win: TB-500 stopped being a problem at week 21
Quick one. Canada here.
thymosin works very differently where I live than in the threads that dominate the front page, and I keep seeing people confidently given advice that simply does not apply outside the US.
Specifics: the route I used took 5 weeks and cost roughly what I expected. The admin was worse than the cost. The thing that would have saved me the most time was knowing which document to ask for at the start.
Happy to answer questions from anyone in the same jurisdiction.
best — the order this archive was captured in
Yeah, identity is the first question.
This is the "correlation is mechanism" thing again. You changed three variables at once.
The confident tone is doing a lot of work that the evidence is not.
Maintenance for 13 months now. Weight moves within about 3kg and the dose is a quarter of what it peaked at.
evidence-level statements required: in vitro, rodent, or human
Mechanistically the bit that matters is handling. It explains most of the early profile and a decent chunk of the outcome.
the 9-letter analogs are speculative
everything else in the vial drawer, handling
the thymosin literature is thin on humans
Yeah, identity is the first question.
Yeah, identity is the first question.
Disagree on that part. 99.2% and 98.1% on the same vial is normal.
supply-chain naming is a mess, ask for HPLC
The confident tone is doing a lot of work that the evidence is not.
Maintenance for 3 months now. Weight moves within about 3kg and the dose is a quarter of what it peaked at.
The confident tone is doing a lot of work that the evidence is not.
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
name the compound precisely, TB-500 and Thymosin Beta-4 are not the same
Disagree. What you are describing is consistent with identity, not with what you concluded.
I love that this community will spend 40 comments on a detail. That pedantry is why the numbers here matter.
evidence-level statements required: in vitro, rodent, or human
Second this question. I have wondered about handling for 23 months and never seen a straight answer.
supply-chain naming is a mess, ask for HPLC
I love that this community will spend 40 comments on a detail.
Adding to this: handling is doing more work than the comment implies.
name the compound precisely, TB-500 and Thymosin Beta-4 are not the same
Slight fix: the number was 99.1, not 93.7. Decimal point, but a fairly consequential one.
Not to be pedantic but secretagogue and research peptides are being used interchangeably and they are not interchangeable in real life.
Not to be pedantic but secretagogue and research peptides are being used interchangeably and they are not interchangeable in real life.
Adding to this: TB-500 is doing more work than the comment implies.
- 1I love that this community will spend 40 comments on a detail. That pedantry…9 comments in this branch · started by u/patient_labslip_log
- 2Yeah, identity is the first question.6 comments in this branch · started by u/piotr_grimaldi